Bionik Laboratories Corp.

42 articles with Bionik Laboratories Corp.

• BIONIK Laboratories Announces Fiscal 2021 Q2 Financial Results

  11/12/2020

  BIONIK Laboratories Corp . (OTCQB: BNKL) , a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced financial results for its second quarter of fiscal year 2021, ending September 30, 2020. Financial highlights for the second quarter of fiscal 2021 and recent weeks include:

• BIONIK Laboratories Announces Sale of New InMotion® ARM/HAND Robotic Device to VA Rehabilitation Research & Development’s Center for Neurorestoration and Neurotechnology

  9/30/2020

  BIONIK Laboratories Announces Sale of New InMotion ® ARM/HAND Robotic Device to VA Rehabilitation Research & Development’s Center for Neurorestoration and Neurotechnology VA-funded center purchases second InMotion ® ARM/HAND interactive therapy system to test new approaches for restoring physical function of veterans with neurologic disease or injury TORONTO & BOSTON--( BUSINESS WIRE )-- BIONIK Laboratories Corp . (OTCQB:BNKL) ("BIONIK" or

• BIONIK Laboratories Announces Fiscal 2020 Financial Results

  6/30/2020

  BIONIK Laboratories Corp . (OTCQB:BNKL) ("BIONIK"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced financial results for the fiscal year ended March 31, 2020. Financial highlights for the fiscal year 2020 and recent weeks include : Reported sales of $2,153,354 for

• BIONIK Laboratories Donates InMotion® Robotic System to Einstein Healthcare Network’s MossRehab for Use in New COVID-19 Rehab Unit

  5/12/2020

  MossRehab, led by renowned Dr. Alberto Esquenazi, utilizing BIONIK’s robotic therapy system in new CORE+ Unit to treat patients infected with or recovering from COVID-19 TORONTO & BOSTON--( BUSINESS WIRE )-- BIONIK Laboratories Corp . (OTCQB:BNKL) ("BIONIK"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced it h

• BIONIK Laboratories Announces Third Quarter Fiscal 2020 Financial Results

  2/14/2020

  BIONIK Laboratories Corp. (OTCQB: BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced financial results for the third quarter of fiscal year 2020, ended December 31, 2019.

• BIONIK Laboratories Announces Regulatory Approval and First Sale of its InMotion® ARM Robotic Technology by its Exclusive Distributor in South Korea

  1/30/2020

  BIONIK Laboratories Corp. (OTCQB:BNKL) ("BIONIK"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced it has received regulatory approval in South Korea, and that its exclusive distributor Curexo secured the first sale for BIONIK’s InMotion® robotic technology in the country, out of Curexo’s existing inventory.

• BIONIK Laboratories Announces Second Quarter Fiscal 2020 Financial Results

  11/15/2019

  BIONIK Laboratories Corp. (OTCQB: BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced financial results for the second quarter of fiscal year 2020, ended September 30, 2019.

• BIONIK Laboratories Appoints Loren Wass as Chief Commercial Officer

  9/4/2019

  Industry veteran brings extensive experience driving the commercialization of robotic technologies within healthcare

• BIONIK Laboratories’ Fiscal Year 2020 Q1 Financial Results Feature 57% Increase in Sales

  8/13/2019

  Financial results for its first quarter of fiscal year 2020, ended June 30, 2019.

• BIONIK Laboratories’ Fiscal 2019 Financial Results Feature 229% Increase in Sales

  7/2/2019

  Reported sales of $3,246,038, an increase of 229% compared to the reported sales of $987,431 in the prior fiscal year.

• BIONIK Laboratories Third Quarter Fiscal 2019 Financial Results Feature 256% Increase in Sales

  2/11/2019

  BIONIK is a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home

• BIONIK Laboratories Launches Next-Generation InMotion ARM/HAND Robotic System to Improve Rehabilitation for Stroke Survivors

  1/23/2019

  Company introduces new technology at the American Physical Therapy Association Combined Sections Meeting January 23-26 in Washington, D.C.

• BIONIK Laboratories Announces Multi-Year Purchase Agreement and Ongoing Relationship with Kindred Hospital Rehabilitation Services for InMotion Arm™ Robotic Systems

  12/17/2018

  Multi-year commitment will place InMotion Arm™ Robots in existing and future Kindred Inpatient Rehabilitation Hospitals across the United States

• BIONIK Laboratories Second Quarter Fiscal 2019 Financial Results Feature 147% Increase in Revenues

  11/13/2018

  BIONIK Laboratories Corp. today announced financial results for the second quarter of fiscal year 2019, ended September 30, 2018.

• Bionik Laboratories Files Registration Statement for Proposed Follow-On Offering

  10/30/2018

  Bionik Laboratories Corp. announced today the filing of a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed underwritten follow-on public offering of shares of its common stock.

• Bionik Laboratories Announces 1-for-150 Reverse Stock Split

  10/29/2018

  Bionik Laboratories Corp. announced that its board of directors has established a ratio of 1-for-150 for the Company's previously approved reverse stock split.

• BIONIK Laboratories Announces Purchase Agreement from Clinique Les Trois Soleils for InMotion Arm™ Robotic System

  10/24/2018

  Leading French rehabilitation facility adds fourth InMotion robotic system to provide enhanced inpatient neurorehabilitation

• Bionik Laboratories Appoints Dr. Audrey D. Thévenon and Charles Matine to its Board of Directors

  9/13/2018

  Gains substantial scientific, marketing and branding expertise

• Bionik Laboratories Reports First Quarter Fiscal 2019 Financial Results

  8/14/2018

  Reported sales of $501,333, up substantially from $87,520 in the prior-year quarter

• Bionik Laboratories Reports Fiscal Year 2018 Financial Results

  6/27/2018

  Strengthened the board of directors with the appointment of Andre Auberton-Herve as chairman and P. Gerald Malone and Joseph Martin as directors, bringing years of strategic, financial and management expertise